Key result
Antiarrhythmic drug therapy fails to reduce progression to AV block in acute MI.
Why the study?
The effects of commonly used antiarrhythmic drugs on atrioventricular conduction in patients with acute myocardial infarction were unclear.
Do antiarrhythmic drugs increase the risk of progression to atrioventricular block in patients with acute myocardial infarction?
Cohort (n=429)
Do antiarrhythmic drugs increase the risk of progression to atrioventricular block in patients with acute myocardial infarction?
Commonly used antiarrhythmic drugs do not adversely affect AV conduction in patients with acute MI who have a narrow QRS and normal PR interval, though caution may be warranted in those with newly acquired bundle branch block.
Answers are grounded in this paper and cite their sources.
Antiarrhythmic use was not linked to higher AV block rates in acute MI with narrow QRS; leaves open effects in conduction disease.
Three hundred fifty-eight of 429 (83%) consecutive patients with acute myocardial infarction (MI) and a normal PR interval received various antiarrhythmic drugs (AD), including lidocaine and/or procainamide, quinidine, digoxin, propranolol or disopyramide. There was no significant difference in the incidence of progression to any degree of atrioventricular (AV) block or to higher degrees of AV block (Mobitz II or third-degree AV block) between those treated and not treated with AD: 38 of 358 (11%) and six of 358 (1.7%) with AD vs 11 of 71 (15%) and two of 71 (2.8%) in the untreated group, respectively. Similarly, there was no significant difference in progression between treated and untreated patients with anterior MI, 14 of 144 (10%) vs five of 32 (16%); inferior MI, 21 of 111 (19%) vs five of 26 (19%), or subendocardial MI, three of 103 (3%) vs one of 12 (8%). Bundle branch block (BBB) (without AV block) was initially present in 89 of 249 (21%). The incidence of AV block (seven of 24, 30%) was higher in treated patients with newly acquired BBB (27 patients) than in the untreated patients (none of three, p less than 0.05). The commonly used ADs did not adversely affect AV conduction in patients with acute MI with narrow QRS and either normal, first-degree, or Mobitz I AV block. Moreover, no subset of patients grouped by infarct location, specific AD used, or BBB (except perhaps for those with newly acquired BBB) appeared to be at risk of development of AV block during AD therapy.
No takes yet. Share an insight, caveat, or question.
Scheinman et al. (1980) conducted a cohort in Acute myocardial infarction (n=429). Antiarrhythmic drugs vs. No antiarrhythmic drugs was evaluated on Progression to any degree of atrioventricular (AV) block. Antiarrhythmic drug therapy did not affect the incidence of progression to any degree of atrioventricular block in patients with acute myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: